Literature DB >> 28848111

An Asian Perspective on Povidone Iodine in Wound Healing.

Paul Bigliardi1, Stefan Langer, Jose Joven Cruz, Sang Wha Kim, Harikrishna Nair, Gulapar Srisawasdi.   

Abstract

Antiseptics, with a broader spectrum of antimicrobial efficacy, lower risk of antibiotic resistance development, and minimal collateral damage to host tissues, are important alternatives to control the bioburden in wounds. Povidone iodine (PVP-I), in use for several decades, has the broadest spectrum of activity, a persistent antimicrobial effect, an ability to penetrate biofilms, and a lack of acquired or cross-resistance. It demonstrates good skin tolerance and low cytotoxicity. However, some reports on PVP-I have raised concerns over allergy, ineffective penetration, and toxic effects on host cells. The majority of these concerns are based on in vitro or rodent wound studies with diverse study designs and outcomes; these results may not be directly applicable in the clinical reality in humans. In this paper, we discuss the efficacy and safety of PVP-I and outline its place in wound healing in Asia, based on an appraisal of recent literature and clinical practice across the region.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Antimicrobial agents; Antiseptic; Povidone iodine; Wound healing

Mesh:

Substances:

Year:  2017        PMID: 28848111     DOI: 10.1159/000479150

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

1.  The use of povidone-iodine and sugar solution in surgical wound dehiscence in the head and neck following radio-chemotherapy.

Authors:  Arianna Di Stadio; Valeria Gambacorta; Maria Cristina Cristi; Massimo Ralli; Simona Pindozzi; Luigi Tassi; Antonio Greco; Giuseppe Lomurno; Ricci Giampietro
Journal:  Int Wound J       Date:  2019-04-10       Impact factor: 3.315

Review 2.  Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.

Authors:  Nicole-Ann Lim; Ooiean Teng; Chester Yan Hao Ng; Lena X Y Bao; Paul Anantharajah Tambyah; Amy M L Quek; Raymond C S Seet
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model.

Authors:  Hala M F El Miniawy; Haithem A Farghali; Marwa S Khattab; Ibrahim A Emam; Essam M Ibrahem; Dina Sabry; Tahany A Ismail
Journal:  Stem Cell Res Ther       Date:  2022-07-30       Impact factor: 8.079

Review 4.  Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment.

Authors:  Zuzanna Łucja Babalska; Marzena Korbecka-Paczkowska; Tomasz M Karpiński
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.